Literature DB >> 31701183

[Progressive maculopathy despite discontinuation of chloroquine treatment-multimodal imaging and review of the literature].

A Rickmann1, S Al-Nawaiseh2, L Ramirez2, S Röhrig3, M Ladewig3, P Szurman2, G Szurman2.   

Abstract

This case report presents a pictorially well-documented case with multimodal images of a progression of maculopathy despite discontinuation of chloroquine treatment in a long-term follow-up over 6 years. Additionally, the current detection methods in screening for early recognition of maculopathy and their prognostic significance are reviewed.

Entities:  

Keywords:  Bull’s eye maculopathy; Chloroquine; Chloroquine maculopathy; Chloroquine phosphate; Systemic lupus erythematosus

Mesh：

Substances：

Year:  2020        PMID： 31701183     DOI： 10.1007/s00347-019-00994-6

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN： 0941-293X            Impact factor:   1.059


  41 in total

1.  Effect of immunosuppressive therapies on survival of systemic lupus erythematosus: a propensity score analysis of a longitudinal cohort.

Authors:  C C Mok; S M Tse; K L Chan; L Y Ho
Journal:  Lupus       Date:  2017-10-31       Impact factor: 2.911

2.  Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment.

Authors:  M L Jewell; D P McCauliffe
Journal:  J Am Acad Dermatol       Date:  2000-06       Impact factor: 11.527

Review 3.  The Diagnosis and Treatment of Systemic Lupus Erythematosus.

Authors:  Annegret Kuhn; Gisela Bonsmann; Hans-Joachim Anders; Peter Herzer; Klaus Tenbrock; Matthias Schneider
Journal:  Dtsch Arztebl Int       Date:  2015-06-19       Impact factor: 5.594

Review 4.  Systemic lupus erythematosus: Diagnosis and clinical management.

Authors:  Andrea Fava; Michelle Petri
Journal:  J Autoimmun       Date:  2018-11-16       Impact factor: 7.094

5.  The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy.

Authors:  Ronald B Melles; Michael F Marmor
Journal:  JAMA Ophthalmol       Date:  2014-12       Impact factor: 7.389

6.  Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging.

Authors:  Mihai Mititelu; Brandon J Wong; Marie Brenner; Paul J Bryar; Lee M Jampol; Amani A Fawzi
Journal:  JAMA Ophthalmol       Date:  2013-09       Impact factor: 7.389

7.  Early morpho-functional changes in patients treated with hydroxychloroquine: a prospective cohort study.

Authors:  Giulio Ruberto; Carlo Bruttini; Carmine Tinelli; Lorenzo Cavagna; Alessandro Bianchi; Giovanni Milano
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-08-27       Impact factor: 3.117

8.  Progression of hydroxychloroquine retinopathy after discontinuation of therapy: case report.

Authors:  L C Wei; S N Chen; C L Ho; Y H Kuo; J D Ho
Journal:  Chang Gung Med J       Date:  2001-05

9.  The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal.

Authors:  Ioannis Mavrikakis; Petros P Sfikakis; Emmanouil Mavrikakis; Kostantinos Rougas; Athanasios Nikolaou; Charalambos Kostopoulos; Myron Mavrikakis
Journal:  Ophthalmology       Date:  2003-07       Impact factor: 12.079

10.  Assessment of hydroxychloroquine maculopathy after cessation of treatment: an optical coherence tomography and multifocal electroretinography study.

Authors:  Marilita M Moschos; Eirini Nitoda; Irini P Chatziralli; Zisis Gatzioufas; Chryssanthi Koutsandrea; George Kitsos
Journal:  Drug Des Devel Ther       Date:  2015-06-11       Impact factor: 4.162
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.